Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aclarion Inc
ACON | US
3.20
USD-0.06
-1.84%
ACON | US
About Aclarion Inc
Sector
Healthcare
Industry
Health Information Services
Earnings date
30/06/2024
As of date
20/03/2026
Close
3.20
Open
3.21
High
3.23
Low
3.05
Aclarion Inc. a healthcare technology company leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM a clinical decision support software. The company was formerly known as Nocimed Inc. and changed its name to Aclarion Inc. in December 2021. Aclarion Inc. was founded in 2008 and is based in Broomfield Colorado.
View LessACON | US
Risk
72.7
Sharpe
-0.87
Luna's Score
36/100
Recommendation
Sell
Luna says (ACON | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
51.0%1 month
72.7%3 months
147.0%6 months
120.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.09
Debt to equity
0.47
Debt to assets
0.25
Ent. to EBITDA
-0.56
Ent. to rev.
25.81
PEG
-
Other Fundamentals
EBITDA
-4.53M
MarketCap
32.14M
MarketCap(USD)
32.14M
Div. yield
-
Op. margin
-10.35K
Erngs. growth
-
Rev. growth
-35.70
Ret. on equity
-714.18
Short ratio
0.47
Short perc.
2.61
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.54
Range1M
1.07
Range3M
7.02
Volumes: Market Activity
Rel. volume
1.11
Price X volume
253.21K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.56 | - | Cheaper |
| Ent. to Revenue | 25.81 | - | Expensive |
| PE Ratio | - | 64.03 | - |
| Price to Book | 1.09 | 6.17 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 146.99 | - | Riskier |
| Debt to Equity | 0.47 | 0.44 | Par |
| Debt to Assets | 0.25 | 0.35 | Cheaper |
| Market Cap | 32.14M | - | Emerging |
